SoftBank founder Masayoshi Son has been thinking about AI in various forms for more than a decade, according to former ...

TheStreet. Every so often, Tesla (TSLA) makes a headline-grabbing move that seems more like a turning point hiding in plain ...

AbbVie (NYSE: ABBV) has long been known for its immunology drugs like Humira, which at one point was the top-selling drug in ...

Wood has been bullish on Tesla's AI pursuits for years, especially the robotaxi business. In fact, Ark's long-run price ...